NATL HEALTH INVESTORS INC (NHI) Fundamental Analysis & Valuation

NYSE:NHI • US63633D1046

Current stock price

82.79 USD
-0.33 (-0.4%)
At close:
82.79 USD
0 (0%)
After Hours:

This NHI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. NHI Profitability Analysis

1.1 Basic Checks

  • NHI had positive earnings in the past year.
  • NHI had a positive operating cash flow in the past year.
  • NHI had positive earnings in each of the past 5 years.
  • In the past 5 years NHI always reported a positive cash flow from operatings.
NHI Yearly Net Income VS EBIT VS OCF VS FCFNHI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M -200M

1.2 Ratios

  • NHI's Return On Assets of 5.08% is amongst the best of the industry. NHI outperforms 93.50% of its industry peers.
  • Looking at the Return On Equity, with a value of 9.33%, NHI belongs to the top of the industry, outperforming 84.55% of the companies in the same industry.
  • NHI's Return On Invested Capital of 5.56% is amongst the best of the industry. NHI outperforms 95.12% of its industry peers.
  • NHI had an Average Return On Invested Capital over the past 3 years of 5.76%. This is above the industry average of 3.13%.
Industry RankSector Rank
ROA 5.08%
ROE 9.33%
ROIC 5.56%
ROA(3y)5.27%
ROA(5y)4.48%
ROE(3y)10.08%
ROE(5y)8.58%
ROIC(3y)5.76%
ROIC(5y)5.44%
NHI Yearly ROA, ROE, ROICNHI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • With an excellent Profit Margin value of 37.80%, NHI belongs to the best of the industry, outperforming 91.87% of the companies in the same industry.
  • NHI's Profit Margin has declined in the last couple of years.
  • With an excellent Operating Margin value of 50.74%, NHI belongs to the best of the industry, outperforming 93.50% of the companies in the same industry.
  • NHI's Operating Margin has declined in the last couple of years.
  • NHI has a Gross Margin of 80.86%. This is amongst the best in the industry. NHI outperforms 82.11% of its industry peers.
  • NHI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 50.74%
PM (TTM) 37.8%
GM 80.86%
OM growth 3Y-0.48%
OM growth 5Y-5.57%
PM growth 3Y16.56%
PM growth 5Y-7.44%
GM growth 3Y-2.16%
GM growth 5Y-3.6%
NHI Yearly Profit, Operating, Gross MarginsNHI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. NHI Health Analysis

2.1 Basic Checks

  • NHI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • NHI has more shares outstanding than it did 1 year ago.
  • NHI has more shares outstanding than it did 5 years ago.
  • NHI has a better debt/assets ratio than last year.
NHI Yearly Shares OutstandingNHI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
NHI Yearly Total Debt VS Total AssetsNHI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • An Altman-Z score of 2.05 indicates that NHI is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 2.05, NHI belongs to the best of the industry, outperforming 95.94% of the companies in the same industry.
  • NHI has a Debt/Equity ratio of 0.76. This is a neutral value indicating NHI is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.76, NHI is in the better half of the industry, outperforming 74.80% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF N/A
Altman-Z 2.05
ROIC/WACC0.72
WACC7.75%
NHI Yearly LT Debt VS Equity VS FCFNHI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 1.19 indicates that NHI should not have too much problems paying its short term obligations.
  • NHI's Current ratio of 1.19 is fine compared to the rest of the industry. NHI outperforms 64.23% of its industry peers.
  • NHI has a Quick Ratio of 1.19. This is a normal value and indicates that NHI is financially healthy and should not expect problems in meeting its short term obligations.
  • NHI's Quick ratio of 1.19 is fine compared to the rest of the industry. NHI outperforms 65.04% of its industry peers.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 1.19
NHI Yearly Current Assets VS Current LiabilitesNHI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. NHI Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 1.34% over the past year.
  • NHI shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -6.07% yearly.
  • The Revenue has grown by 12.07% in the past year. This is quite good.
  • The Revenue has been growing slightly by 2.45% on average over the past years.
EPS 1Y (TTM)1.34%
EPS 3Y26.84%
EPS 5Y-6.07%
EPS Q2Q%-1.23%
Revenue 1Y (TTM)12.07%
Revenue growth 3Y10.53%
Revenue growth 5Y2.45%
Sales Q2Q%23.4%

3.2 Future

  • NHI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.45% yearly.
  • The Revenue is expected to grow by 14.69% on average over the next years. This is quite good.
EPS Next Y11.53%
EPS Next 2Y6.79%
EPS Next 3Y3.45%
EPS Next 5YN/A
Revenue Next Year16.12%
Revenue Next 2Y11.8%
Revenue Next 3Y14.74%
Revenue Next 5Y14.69%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NHI Yearly Revenue VS EstimatesNHI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
NHI Yearly EPS VS EstimatesNHI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

2

4. NHI Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 27.41 indicates a quite expensive valuation of NHI.
  • Based on the Price/Earnings ratio, NHI is valued a bit cheaper than 68.29% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 25.23, NHI is valued at the same level.
  • Based on the Price/Forward Earnings ratio of 24.58, the valuation of NHI can be described as rather expensive.
  • 84.55% of the companies in the same industry are more expensive than NHI, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of NHI to the average of the S&P500 Index (22.51), we can say NHI is valued inline with the index average.
Industry RankSector Rank
PE 27.41
Fwd PE 24.58
NHI Price Earnings VS Forward Price EarningsNHI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, NHI is valued expensively inside the industry as 80.49% of the companies are valued cheaper.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 18.97
NHI Per share dataNHI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • NHI has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.38
PEG (5Y)N/A
EPS Next 2Y6.79%
EPS Next 3Y3.45%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. NHI Dividend Analysis

5.1 Amount

  • NHI has a Yearly Dividend Yield of 4.34%, which is a nice return.
  • NHI's Dividend Yield is comparable with the industry average which is at 7.32.
  • Compared to an average S&P500 Dividend Yield of 1.90, NHI pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.34%

5.2 History

  • The dividend of NHI decreases each year by -3.59%.
  • NHI has been paying a dividend for at least 10 years, so it has a reliable track record.
  • NHI has decreased its dividend in the last 3 years.
Dividend Growth(5Y)-3.59%
Div Incr Years0
Div Non Decr Years2
NHI Yearly Dividends per shareNHI Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

5.3 Sustainability

  • 119.52% of the earnings are spent on dividend by NHI. This is not a sustainable payout ratio.
DP119.52%
EPS Next 2Y6.79%
EPS Next 3Y3.45%
NHI Yearly Income VS Free CF VS DividendNHI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M
NHI Dividend Payout.NHI Dividend Payout, showing the Payout Ratio.NHI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

NHI Fundamentals: All Metrics, Ratios and Statistics

NATL HEALTH INVESTORS INC

NYSE:NHI (3/26/2026, 8:04:00 PM)

After market: 82.79 0 (0%)

82.79

-0.33 (-0.4%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-26
Earnings (Next)05-04
Inst Owners73.45%
Inst Owner Change-0.55%
Ins Owners0.9%
Ins Owner Change14.89%
Market Cap4.01B
Revenue(TTM)375.63M
Net Income(TTM)141.98M
Analysts76.67
Price Target87.34 (5.5%)
Short Float %2.63%
Short Ratio4.6
Dividend
Industry RankSector Rank
Dividend Yield 4.34%
Yearly Dividend3.61
Dividend Growth(5Y)-3.59%
DP119.52%
Div Incr Years0
Div Non Decr Years2
Ex-Date03-31
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-5.1%
Min EPS beat(2)-8.3%
Max EPS beat(2)-1.91%
EPS beat(4)1
Avg EPS beat(4)-1.5%
Min EPS beat(4)-8.3%
Max EPS beat(4)4.29%
EPS beat(8)4
Avg EPS beat(8)0.17%
EPS beat(12)6
Avg EPS beat(12)2.26%
EPS beat(16)7
Avg EPS beat(16)-10.94%
Revenue beat(2)2
Avg Revenue beat(2)8.55%
Min Revenue beat(2)5.78%
Max Revenue beat(2)11.32%
Revenue beat(4)4
Avg Revenue beat(4)6.17%
Min Revenue beat(4)3.26%
Max Revenue beat(4)11.32%
Revenue beat(8)8
Avg Revenue beat(8)5.58%
Revenue beat(12)11
Avg Revenue beat(12)4.1%
Revenue beat(16)12
Avg Revenue beat(16)1.1%
PT rev (1m)0%
PT rev (3m)-0.44%
EPS NQ rev (1m)-4.4%
EPS NQ rev (3m)-4.4%
EPS NY rev (1m)0%
EPS NY rev (3m)1.75%
Revenue NQ rev (1m)4.32%
Revenue NQ rev (3m)6.57%
Revenue NY rev (1m)1.09%
Revenue NY rev (3m)5.92%
Valuation
Industry RankSector Rank
PE 27.41
Fwd PE 24.58
P/S 10.67
P/FCF N/A
P/OCF 16.94
P/B 2.63
P/tB 2.63
EV/EBITDA 18.97
EPS(TTM)3.02
EY3.65%
EPS(NY)3.37
Fwd EY4.07%
FCF(TTM)-1.19
FCFYN/A
OCF(TTM)4.89
OCFY5.9%
SpS7.76
BVpS31.44
TBVpS31.44
PEG (NY)2.38
PEG (5Y)N/A
Graham Number46.22
Profitability
Industry RankSector Rank
ROA 5.08%
ROE 9.33%
ROCE 7.04%
ROIC 5.56%
ROICexc 5.6%
ROICexgc 5.62%
OM 50.74%
PM (TTM) 37.8%
GM 80.86%
FCFM N/A
ROA(3y)5.27%
ROA(5y)4.48%
ROE(3y)10.08%
ROE(5y)8.58%
ROIC(3y)5.76%
ROIC(5y)5.44%
ROICexc(3y)5.81%
ROICexc(5y)5.5%
ROICexgc(3y)5.84%
ROICexgc(5y)5.53%
ROCE(3y)7.29%
ROCE(5y)6.89%
ROICexgc growth 3Y6.24%
ROICexgc growth 5Y-1.2%
ROICexc growth 3Y6.24%
ROICexc growth 5Y-1.17%
OM growth 3Y-0.48%
OM growth 5Y-5.57%
PM growth 3Y16.56%
PM growth 5Y-7.44%
GM growth 3Y-2.16%
GM growth 5Y-3.6%
F-Score5
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF N/A
Debt/EBITDA 4.29
Cap/Depr 363.26%
Cap/Sales 78.28%
Interest Coverage 3.7
Cash Conversion 87.12%
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 1.19
Altman-Z 2.05
F-Score5
WACC7.75%
ROIC/WACC0.72
Cap/Depr(3y)218.38%
Cap/Depr(5y)144.44%
Cap/Sales(3y)46.96%
Cap/Sales(5y)31.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.34%
EPS 3Y26.84%
EPS 5Y-6.07%
EPS Q2Q%-1.23%
EPS Next Y11.53%
EPS Next 2Y6.79%
EPS Next 3Y3.45%
EPS Next 5YN/A
Revenue 1Y (TTM)12.07%
Revenue growth 3Y10.53%
Revenue growth 5Y2.45%
Sales Q2Q%23.4%
Revenue Next Year16.12%
Revenue Next 2Y11.8%
Revenue Next 3Y14.74%
Revenue Next 5Y14.69%
EBIT growth 1Y1.11%
EBIT growth 3Y10%
EBIT growth 5Y-3.26%
EBIT Next Year58.98%
EBIT Next 3Y18.87%
EBIT Next 5YN/A
FCF growth 1Y-215.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.86%
OCF growth 3Y8.48%
OCF growth 5Y0.38%

NATL HEALTH INVESTORS INC / NHI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of NATL HEALTH INVESTORS INC (NHI) stock?

ChartMill assigns a fundamental rating of 5 / 10 to NHI.


What is the valuation status for NHI stock?

ChartMill assigns a valuation rating of 2 / 10 to NATL HEALTH INVESTORS INC (NHI). This can be considered as Overvalued.


How profitable is NATL HEALTH INVESTORS INC (NHI) stock?

NATL HEALTH INVESTORS INC (NHI) has a profitability rating of 7 / 10.


What are the PE and PB ratios of NATL HEALTH INVESTORS INC (NHI) stock?

The Price/Earnings (PE) ratio for NATL HEALTH INVESTORS INC (NHI) is 27.41 and the Price/Book (PB) ratio is 2.63.


Is the dividend of NATL HEALTH INVESTORS INC sustainable?

The dividend rating of NATL HEALTH INVESTORS INC (NHI) is 4 / 10 and the dividend payout ratio is 119.52%.